oxalic acid has been researched along with Disease Models, Animal in 14 studies
Oxalic Acid: A strong dicarboxylic acid occurring in many plants and vegetables. It is produced in the body by metabolism of glyoxylic acid or ascorbic acid. It is not metabolized but excreted in the urine. It is used as an analytical reagent and general reducing agent.
oxalic acid : An alpha,omega-dicarboxylic acid that is ethane substituted by carboxyl groups at positions 1 and 2.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nephrolithiasis is one of the most common urinary tract disorders, with the majority of kidney stones composed of calcium oxalate (CaOx)." | 7.83 | Sulfate and thiosulfate inhibit oxalate transport via a dPrestin (Slc26a6)-dependent mechanism in an insect model of calcium oxalate nephrolithiasis. ( Anderson, JB; Cabrero, P; Dow, JA; Gallo, CJ; Hirata, T; Landry, GM; Romero, MF, 2016) |
| "The use of hydroxyproline (HP) to generate hyperoxaluria in the rat is a problem because it is impossible to separate the effect of oxalate on renal injury from the effects of HP and the large array of metabolic intermediates formed when HP is converted to oxalate." | 7.77 | Improved methodology to induce hyperoxaluria without treatment using hydroxyproline. ( Garrett, MR; Hung, LY; Mandel, NS; Wiessner, JH; Wille, DF, 2011) |
| "Experimental induction of hyperoxaluria by ethylene glycol (EG) administration is disapproved as it causes metabolic acidosis while the oral administration of chemically synthesized potassium oxalate (KOx) diet does not mimic our natural system." | 3.88 | Oral administration of oxalate-enriched spinach extract as an improved methodology for the induction of dietary hyperoxaluric nephrocalcinosis in experimental rats. ( Albert, A; Ganesan, D; Govindan Sadasivam, S; Mariaraj Sivakumar, S; Paul, E; Ponnusamy, S; Prabhakaran, R; Tiwari, V, 2018) |
| "Nephrolithiasis is one of the most common urinary tract disorders, with the majority of kidney stones composed of calcium oxalate (CaOx)." | 3.83 | Sulfate and thiosulfate inhibit oxalate transport via a dPrestin (Slc26a6)-dependent mechanism in an insect model of calcium oxalate nephrolithiasis. ( Anderson, JB; Cabrero, P; Dow, JA; Gallo, CJ; Hirata, T; Landry, GM; Romero, MF, 2016) |
| "The use of hydroxyproline (HP) to generate hyperoxaluria in the rat is a problem because it is impossible to separate the effect of oxalate on renal injury from the effects of HP and the large array of metabolic intermediates formed when HP is converted to oxalate." | 3.77 | Improved methodology to induce hyperoxaluria without treatment using hydroxyproline. ( Garrett, MR; Hung, LY; Mandel, NS; Wiessner, JH; Wille, DF, 2011) |
| "Empagliflozin treatment started from day 0 of oxalate feeding had no effect on the decline of glomerular filtration rate, crystal deposition, blood urea nitrogen or serum creatinine levels on day 7 and 14." | 1.46 | Sodium glucose transporter-2 inhibition has no renoprotective effects on non-diabetic chronic kidney disease. ( Anders, HJ; Ma, Q; Steiger, S, 2017) |
| "Urolithiasis is a multifaceted process, progressing from urine supersaturation to the formation of mature renal calculi." | 1.39 | Molecular mechanisms involved in the protective effect of the chloroform extract of Selaginella lepidophylla (Hook. et Grev.) Spring in a lithiasic rat model. ( Christophe, BO; Estela, MC; Juanita, NM; Mirian, EC, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Sayed, AA | 1 |
| Fahmy, SR | 1 |
| Soliman, AM | 1 |
| Mohamed, DM | 1 |
| Ma, Q | 1 |
| Steiger, S | 1 |
| Anders, HJ | 2 |
| Albert, A | 2 |
| Tiwari, V | 1 |
| Paul, E | 2 |
| Ponnusamy, S | 2 |
| Ganesan, D | 1 |
| Prabhakaran, R | 1 |
| Mariaraj Sivakumar, S | 1 |
| Govindan Sadasivam, S | 1 |
| Mishra, SR | 1 |
| Vignesh, AG | 1 |
| Sivakumar, SM | 1 |
| Sivasamy, G | 1 |
| Sadasivam, SG | 1 |
| Mirian, EC | 1 |
| Juanita, NM | 1 |
| Christophe, BO | 1 |
| Estela, MC | 1 |
| Weljie, AM | 1 |
| Meerlo, P | 1 |
| Goel, N | 1 |
| Sengupta, A | 1 |
| Kayser, MS | 1 |
| Abel, T | 1 |
| Birnbaum, MJ | 1 |
| Dinges, DF | 1 |
| Sehgal, A | 1 |
| Landry, GM | 1 |
| Hirata, T | 1 |
| Anderson, JB | 1 |
| Cabrero, P | 1 |
| Gallo, CJ | 1 |
| Dow, JA | 1 |
| Romero, MF | 1 |
| Mulay, SR | 1 |
| Eberhard, JN | 1 |
| Pfann, V | 1 |
| Marschner, JA | 1 |
| Darisipudi, MN | 1 |
| Daniel, C | 1 |
| Romoli, S | 1 |
| Desai, J | 1 |
| Grigorescu, M | 1 |
| Kumar, SV | 1 |
| Rathkolb, B | 1 |
| Wolf, E | 1 |
| Hrabě de Angelis, M | 1 |
| Bäuerle, T | 1 |
| Dietel, B | 1 |
| Wagner, CA | 1 |
| Amann, K | 1 |
| Eckardt, KU | 1 |
| Aronson, PS | 1 |
| Knauf, F | 1 |
| Wiessner, JH | 1 |
| Garrett, MR | 1 |
| Hung, LY | 1 |
| Wille, DF | 1 |
| Mandel, NS | 1 |
| Hossain, RZ | 1 |
| Ogawa, Y | 1 |
| Morozumi, M | 1 |
| Hokama, S | 1 |
| Uchida, A | 1 |
| Sugaya, K | 1 |
| Yasui, T | 1 |
| Fujita, K | 1 |
| Sasaki, S | 1 |
| Sato, M | 1 |
| Sugimoto, M | 1 |
| Hirota, S | 1 |
| Kitamura, Y | 1 |
| Nomura, S | 1 |
| Kohri, K | 1 |
| Hamamoto, DT | 1 |
| Forkey, MW | 1 |
| Davis, WL | 1 |
| Kajander, KC | 1 |
| Simone, DA | 1 |
| Buck, AC | 1 |
| Davies, RL | 1 |
| Harrison, T | 1 |
| Blakemore, WF | 1 |
| Heath, MF | 1 |
| Bennett, MJ | 1 |
| Cromby, CH | 1 |
| Pollitt, RJ | 1 |
1 trial available for oxalic acid and Disease Models, Animal
| Article | Year |
|---|---|
Oxalic acid and diacylglycerol 36:3 are cross-species markers of sleep debt.
Topics: Animals; Biomarkers; Circadian Rhythm; Diglycerides; Disease Models, Animal; Energy Metabolism; Fema | 2015 |
13 other studies available for oxalic acid and Disease Models, Animal
| Article | Year |
|---|---|
Antinephrolithiatic activity of Ananas comosus extract against experimentally induced renal calculi in rats.
Topics: Ananas; Animals; Antioxidants; Disease Models, Animal; Kidney; Kidney Calculi; Male; Oxalic Acid; Ox | 2020 |
Sodium glucose transporter-2 inhibition has no renoprotective effects on non-diabetic chronic kidney disease.
Topics: Animals; Benzhydryl Compounds; Blood Urea Nitrogen; Disease Models, Animal; Glomerular Filtration Ra | 2017 |
Oral administration of oxalate-enriched spinach extract as an improved methodology for the induction of dietary hyperoxaluric nephrocalcinosis in experimental rats.
Topics: Administration, Oral; Animals; Biomarkers; Crystallization; Disease Models, Animal; Ethylene Glycol; | 2018 |
Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats.
Topics: Alanine Racemase; Animals; Bacterial Proteins; Calcium; Calcium Oxalate; Carboxy-Lyases; Cell Adhesi | 2018 |
Molecular mechanisms involved in the protective effect of the chloroform extract of Selaginella lepidophylla (Hook. et Grev.) Spring in a lithiasic rat model.
Topics: Animals; Apoptosis; ATP-Binding Cassette Transporters; Chloroform; Creatinine; Disease Models, Anima | 2013 |
Sulfate and thiosulfate inhibit oxalate transport via a dPrestin (Slc26a6)-dependent mechanism in an insect model of calcium oxalate nephrolithiasis.
Topics: Animals; Anion Transport Proteins; Antiporters; Calcium Oxalate; Disease Models, Animal; Drosophila | 2016 |
Oxalate-induced chronic kidney disease with its uremic and cardiovascular complications in C57BL/6 mice.
Topics: Animals; Disease Models, Animal; Fibroblast Growth Factor-23; Fibrosis; Hypertension; Mice; Mice, In | 2016 |
Improved methodology to induce hyperoxaluria without treatment using hydroxyproline.
Topics: Animals; Crystallization; Disease Models, Animal; Hydroxyproline; Hyperoxaluria; Kidney; Male; Oxali | 2011 |
Urinary response to an oxalic acid load is influenced by the timing of calcium loading in rats.
Topics: Analysis of Variance; Animals; Calcium; Calcium Oxalate; Dietary Supplements; Disease Models, Animal | 2005 |
Expression of bone matrix proteins in urolithiasis model rats.
Topics: Animals; Blood Urea Nitrogen; Blotting, Northern; Calcium Oxalate; Calcium-Binding Proteins; Choleca | 1999 |
The role of pH and osmolarity in evoking the acetic acid-induced wiping response in a model of nociception in frogs.
Topics: Acetic Acid; Animals; Behavior, Animal; Buffers; Disease Models, Animal; Epidermis; Formates; Hydroc | 2000 |
The protective role of eicosapentaenoic acid [EPA] in the pathogenesis of nephrolithiasis.
Topics: Adult; Aged; Animals; Calcium; Disease Models, Animal; Drug Evaluation; Drug Evaluation, Preclinical | 1991 |
Primary hyperoxaluria and L-glyceric aciduria in the cat.
Topics: Acute Kidney Injury; Animals; Cat Diseases; Cats; Disease Models, Animal; Female; Glyceric Acids; Hy | 1988 |